In HER2-positive breast cancer patients with brain metastases treated with trastuzumab and capecitabine, tucatinib increased median overall survival from 12 months to 18.1 months in a phase 2 trial. Medscape Medical News …read more
Labor and delivery units may need to consider regional prevalence of COVID-19 when deciding whether to test asymptomatic pregnant women for SARS-CoV-2 infection at the time of admission. Medscape Medical News …read more
Among women who underwent a planned delivery in a New York City health system during the first half of April, the rate of asymptomatic SARS-CoV-2 infection was 16%, according to a study. …read more
The mouths of healthy e-cigarette users resemble those of patients with severe periodontal disease, countering claims that vaping is a safer alternative than conventional smoking, researchers found. Medscape Medical News …read more
Autopsy findings from patients who have died from COVID-19 shed light on the underlying pathology and resulting clinical symptoms. Medscape Medical News …read more
Thirteen lots of the combination T4/T3 product have been voluntarily recalled as they may contain 115% of the labeled amount of T3. Patients should not stop taking the pills without medical advice. News Alerts …read more
Phexxi (lactic acid, citric acid and potassium bitartrate) has been approved for the prevention of pregnancy in women of reproductive potential. FDA Approvals …read more
As people are social distancing and staying at home, domestic violence is increasing, and people are at risk. Experts say you can intervene, even from a distance. Medscape Medical News …read more
Does risk for airborne transmission change according to how many people are in the room? Medscape Internal Medicine …read more
Although the prevalence of screening has risen in recent years, many women could be suffering in silence, data from the US Centers for Disease Control and Prevention suggest. Medscape Medical News …read more